Interestingly, this H3K9-independent activity of EHMT1 in prostate cancer is similar to the previously reported polycomb-independent activity of EZH2, which is regulated by its phosphorylation at serine 21 (6). The gene discussed is EZH2; the disease is prostate cancer.